SLIDE uncovers a keratinocyte-centered signal in systemic sclerosis
An interpretable machine-learning analysis of multi-omic systemic-sclerosis data identified an unexplored keratinocyte-centered signature, validated by protein staining, and a previously unreported interaction between myeloid-cell and fibroblast states and macrophage HLA signaling. The same study also analyzed CD4 T-cell clonal expansion, but this record treats the paper's disease-mechanism findings as one discovery.
Technology: SLIDE (Significant Latent Factor Interaction Discovery and Exploration)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: An interpretable machine-learning analysis of multi-omic systemic-sclerosis data identified an unexplored keratinocyte-centered signature, validated by protein staining, and a previously unreported interaction between myeloid-cell and fibroblast states and macrophage HLA signaling.
- Still unknown: The paper reports computationally identified relationships and validation of one signature by protein staining; these findings do not by themselves establish causal mechanisms or clinical utility.
- AI role: SLIDE integrated single-cell and spatial multi-omic data, identified interacting latent factors associated with systemic-sclerosis disease severity, and surfaced candidate mechanisms; the keratinocyte signal was checked with protein staining by the study team.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11588359/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 37 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.